IOM Argument to End 510(k)s Is Defended in FDLI Report

The FDA should establish a new standard for premarket clearance to tell the difference between products that can be approved based on predicate devices alone and those that need more rigorous postmarket approval, says one legal expert. But more research is needed to make the distinction.
Devices & Diagnostics Letter